517 related articles for article (PubMed ID: 20530699)
41. Scaffold hopping approach to a new series of smoothened antagonists.
Lu W; Geng D; Sun Z; Yang Z; Ma H; Zheng J; Zhang X
Bioorg Med Chem Lett; 2014 May; 24(10):2300-4. PubMed ID: 24726807
[TBL] [Abstract][Full Text] [Related]
42. Molecular docking study of natural alkaloids as multi-targeted hedgehog pathway inhibitors in cancer stem cell therapy.
Mayank ; Jaitak V
Comput Biol Chem; 2016 Jun; 62():145-54. PubMed ID: 26278973
[TBL] [Abstract][Full Text] [Related]
43. Hedgehog Pathway Inhibitors against Tumor Microenvironment.
Gampala S; Yang JY
Cells; 2021 Nov; 10(11):. PubMed ID: 34831357
[TBL] [Abstract][Full Text] [Related]
44. Digging a hole under Hedgehog: downstream inhibition as an emerging anticancer strategy.
Di Magno L; Coni S; Di Marcotullio L; Canettieri G
Biochim Biophys Acta; 2015 Aug; 1856(1):62-72. PubMed ID: 26080084
[TBL] [Abstract][Full Text] [Related]
45. Salinomycin exerts anticancer effects on human breast carcinoma MCF-7 cancer stem cells via modulation of Hedgehog signaling.
Lu Y; Ma W; Mao J; Yu X; Hou Z; Fan S; Song B; Wang H; Li J; Kang L; Liu P; Liu Q; Li L
Chem Biol Interact; 2015 Feb; 228():100-7. PubMed ID: 25499043
[TBL] [Abstract][Full Text] [Related]
46. Design of Hedgehog pathway inhibitors for cancer treatment.
Bariwal J; Kumar V; Dong Y; Mahato RI
Med Res Rev; 2019 May; 39(3):1137-1204. PubMed ID: 30484872
[TBL] [Abstract][Full Text] [Related]
47. Activation of Hedgehog pathway in gastrointestinal cancers.
Yang L; Su X; Xie J
Vitam Horm; 2012; 88():461-72. PubMed ID: 22391316
[TBL] [Abstract][Full Text] [Related]
48. A novel hedgehog inhibitor iG2 suppresses tumorigenesis by impairing self-renewal in human bladder cancer.
Zhu L; Ni C; Dong B; Zhang Y; Shi Y; Niu H; Li C
Cancer Med; 2016 Sep; 5(9):2579-86. PubMed ID: 27465044
[TBL] [Abstract][Full Text] [Related]
49. Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer.
Brechbiel J; Miller-Moslin K; Adjei AA
Cancer Treat Rev; 2014 Jul; 40(6):750-9. PubMed ID: 24613036
[TBL] [Abstract][Full Text] [Related]
50. LncRNA-Hh Strengthen Cancer Stem Cells Generation in Twist-Positive Breast Cancer via Activation of Hedgehog Signaling Pathway.
Zhou M; Hou Y; Yang G; Zhang H; Tu G; Du YE; Wen S; Xu L; Tang X; Tang S; Yang L; Cui X; Liu M
Stem Cells; 2016 Jan; 34(1):55-66. PubMed ID: 26418365
[TBL] [Abstract][Full Text] [Related]
51. Novel neutralizing hedgehog antibody MEDI-5304 exhibits antitumor activity by inhibiting paracrine hedgehog signaling.
Michaud NR; Wang Y; McEachern KA; Jordan JJ; Mazzola AM; Hernandez A; Jalla S; Chesebrough JW; Hynes MJ; Belmonte MA; Wang L; Kang JS; Jovanovic J; Laing N; Jenkins DW; Hurt E; Liang M; Frantz C; Hollingsworth RE; Simeone DM; Blakey DC; Bedian V
Mol Cancer Ther; 2014 Feb; 13(2):386-98. PubMed ID: 24344235
[TBL] [Abstract][Full Text] [Related]
52. The Hedgehog signaling pathway as a target for anticancer drug discovery.
Borzillo GV; Lippa B
Curr Top Med Chem; 2005; 5(2):147-57. PubMed ID: 15853643
[TBL] [Abstract][Full Text] [Related]
53. Hedgehog/GLI signaling in tumor immunity - new therapeutic opportunities and clinical implications.
Grund-Gröschke S; Stockmaier G; Aberger F
Cell Commun Signal; 2019 Dec; 17(1):172. PubMed ID: 31878932
[TBL] [Abstract][Full Text] [Related]
54. The Role of Smoothened in Cancer.
Jeng KS; Sheen IS; Leu CM; Tseng PH; Chang CF
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962123
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of Pancreatic Cancer Cell-Induced Paracrine Hedgehog Signaling by Liver X Receptor Agonists and Oxy16, a Naturally Occurring Oxysterol.
Wang F; Stappenbeck F; Matsui W; Parhami F
J Cell Biochem; 2017 Mar; 118(3):499-509. PubMed ID: 27490478
[TBL] [Abstract][Full Text] [Related]
56. The Hedgehog signaling pathway promotes chemotherapy resistance via multidrug resistance protein 1 in ovarian cancer.
Zhang H; Hu L; Cheng M; Wang Q; Hu X; Chen Q
Oncol Rep; 2020 Dec; 44(6):2610-2620. PubMed ID: 33125122
[TBL] [Abstract][Full Text] [Related]
57. Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells.
Koike Y; Ohta Y; Saitoh W; Yamashita T; Kanomata N; Moriya T; Kurebayashi J
Breast Cancer; 2017 Sep; 24(5):683-693. PubMed ID: 28144905
[TBL] [Abstract][Full Text] [Related]
58. Recent patents for Hedgehog pathway inhibitors for the treatment of malignancy.
Tremblay MR; Nesler M; Weatherhead R; Castro AC
Expert Opin Ther Pat; 2009 Aug; 19(8):1039-56. PubMed ID: 19505195
[TBL] [Abstract][Full Text] [Related]
59. Small molecule inhibitors of the hedgehog signaling pathway for the treatment of cancer.
Yun JI; Kim HR; Park H; Kim SK; Lee J
Arch Pharm Res; 2012 Aug; 35(8):1317-33. PubMed ID: 22941475
[TBL] [Abstract][Full Text] [Related]
60. Hedgehog pathway inhibitors: a patent review (2009--present).
Hadden MK
Expert Opin Ther Pat; 2013 Mar; 23(3):345-61. PubMed ID: 23294277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
